Vantis

Otterspace raises $3.7m in pre-seed funding, launches private beta to coordinate internet-native organizations with non-transferable tokens

Vantis

Vantis enables continuous patient-centred treatment of heart disease through a mobile app personalised for each patient, continuous measurement of relevant vital signs through devices with dedicated Vantis integration and therapy monitoring with automated data analysis complemented by the doctor in the background.

DeepL to elevate AI research with new investment

Calvin Risk closes a $1.5M Pre-Seed round to help companies deploy and manage trustworthy AI

LatticeFlow Secures $12 Million to Accelerate Platform to Eliminate AI Data and Model Blind Spots in Computer Vision

Otterspace raises $3.7m in pre-seed funding, launches private beta to coordinate internet-native organizations with non-transferable tokens

Demoboost raises EUR 1.7 million pre-seed to transform how software is bought and sold

Ledgy raises $22 million Series B to fund European expansion

Part 1 | Mastering Product Management Basics: Vision & Roadmap

ottonova defies difficult market conditions, raising EUR 34 million

i2x receives €11 million in funding and appoints second managing director

SumUp raises €590 million and celebrates 10 years of supporting small merchants

Get to know Vantis